Gastrointestinal Cancer
News
Adding cetuximab to chemoradiotherapy harmful in esophageal cancer
Major Finding: Adding cetuximab to chemoradiotherapy for localized esophageal cancer was associated with significantly shorter median survival...
Audio
Community Oncology Podcast - Pretreatment PET in eosphageal cancer
Conference Coverage
Second-line agent for gastroesophageal adenocarcinoma ups survival
Major Finding: Patients who failed first-line treatment for metastatic gastric or gastroesophageal junction adenocarcinoma lived a median of 5.2...
News
FDA approves bevacizumab for second-line combinations
News
Resecting residual gastrointestinal stromal tumors improved survival
Major Finding: Time to tumor progression was 88 months in 42 patients who had surgery for residual disease and 42 months in 92 patients given...
News
Second-line docetaxel benefits seen for esophagogastric cancers
Major Finding: Docetaxel significantly increased overall survival from a median of 3.6 months to 5.2 months and reduced pain scores in patients...
Conference Coverage
Risk of anal cancer is high in HIV-infected people
News
Statins cut risk of hepatocellular carcinoma
Major Finding: Statin therapy reduced the risk of developing hepatocellular carcinoma by 37% overall; the risk reduction was stronger (48%) in...
News
Lymph node count may not be best predictor of colon cancer survival
Major Finding: Lymph node count of 12 or higher was not associated with better 5-year survival rates in patients undergoing surgery to treat colon...
News
Ten percent of neoplastic polyps may be incompletely resected
Major Finding: Ten percent of neoplastic polyps (5-20 mm) were not resected completely, as evidenced by neoplastic tissue in biopsies from the...
News
Poor performance seen after optical biopsy training
Major Finding: Three of 12 community gastroenterologists learned to distinguish adenomatous from hyperplastic colon polyps 5 mm in size or smaller...